SCHEMBL16887553

SCHEMBL16887553

CC(=O)N1CCC(C#N)C1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.38
EPHX2 P34913 4/20 0.37
EPHX1 P07099 2/20 0.37
CHRNB2 P17787 3/20 0.36
CHRNA3 P32297 3/20 0.36
CHRNA4 P43681 3/20 0.36
CHRNB3 Q05901 1/20 0.36
CHRNA6 Q15825 1/20 0.36
CYP1A2 P05177 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CHRNB4 P30926 2/20 0.35
JAK2 O60674 2/20 0.34
JAK1 P23458 2/20 0.34
JAK3 P52333 2/20 0.34
KDM4E B2RXH2 1/20 0.33
CHRNA7 P36544 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
QDPR P09417 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18478943 0.89 ALDH1A1 (0.40) DPP4EPHX2EPHX1CHRNB2CHRNA3
SCHEMBL18478125 0.89 ALDH1A1 (0.40) DPP4EPHX2EPHX1CHRNB2CHRNA3
SCHEMBL6107767 0.88 EPHX2 (0.43) DPP4EPHX2EPHX1CYP1A2TDP1
SCHEMBL27510701 0.83 F2R (0.36) DPP4JAK2JAK1JAK3
SCHEMBL8141531 0.83
SCHEMBL16416429 0.82 JAK1 (0.33) JAK2JAK1JAK3KDM4E
SCHEMBL5127466 0.82 JAK1 (0.33) JAK2JAK1JAK3KDM4E
SCHEMBL4666715 0.82 JAK1 (0.33) JAK2JAK1JAK3KDM4E
SCHEMBL27626212 0.80 GAA (0.33) DPP4JAK2JAK1JAK3
SCHEMBL15796013 0.80 JAK1 (0.32) JAK2JAK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021053617-A1 MLL1 INHIBITORS AND ANTI-CANCER AGENTS NOVARTIS AG (CH) 2021-03-25 WO disclosed
EP-3092229-B1 PYRROLIDINYL SULFONE DERIVATIVES AND THEIR USE AS ROR GAMMA MODULATORS BRISTOL MYERS SQUIBB CO (US) 2018-03-28 EP disclosed
WO-2015103509-A1 PYRROLIDINYL SULFONE DERIVATIVES AND THEIR USE AS ROR GAMMA MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-07-09 WO disclosed